Company Overview of Hypnion, Inc.
Hypnion, Inc., a neuroscience drug discovery and development company, focuses on the development of novel therapeutics for the treatment of central nervous system disorders. The company provides SCORE-2004, a sleep-wake drug discovery system for the pre-clinical testing of non-addictive sleep disorder drug candidates, as well as measures the drugs impact on sleep and wake parameters. It serves sleep and wake-alertness disorder, and circadian rhythm abnormalities markets. The company was founded in 2000 and is headquartered in Lexington, Massachusetts. Hypnion, Inc. operates as a subsidiary of Eli Lilly and Company.
500 Patriot Way
Lexington, MA 02421
Founded in 2000
Key Executives for Hypnion, Inc.
Similar Private Companies By Industry
|Atrium Biotech Investments, Inc.||United States|
|BioChemics, Inc.||United States|
|Sciegen Pharmaceuticals, Inc.||United States|
|Vida Cannabis Corp.||United States|
|Angiotech Pharmaceuticals (US), Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Hypnion, Inc., please visit www.hypnion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.